Out of 8 analysts covering Teladoc Inc (NYSE:TDOC), 10 rate it “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. Teladoc Inc was the topic in 18 analyst reports since July 27, 2015 according to StockzIntelligence Inc. Below is a list of Teladoc Inc (NYSE:TDOC) latest ratings and price target changes.
07/03/2016 Broker: SunTrust Rating: Buy Old Target: $37.00 New Target: $21.00 Maintain
12/01/2016 Broker: Deutsche Bank Rating: Buy Old Target: $34.0 New Target: $30.0 Maintain
12/01/2016 Broker: FBR Capital Rating: Outperform Old Target: $40.0 New Target: $36.0 Maintain
06/01/2016 Broker: Stifel Nicolaus Rating: Hold Initiate
03/11/2015 Broker: Cowen & Co Rating: Outperform Old Target: $39.00 New Target: $38.00 Target Down
The stock increased 2.04% or $0.21 on April 8, hitting $10.52. Teladoc Inc (NYSE:TDOC) has declined 52.51% since September 2, 2015 and is downtrending. It has underperformed by 57.57% the S&P500.
Teladoc, Inc. is a telehealth company. The company has a market cap of $414.37 million. The Firm offers an on-demand healthcare platform, through mobile devices, Internet, video and phone. It currently has negative earnings. The Company’s solution connects clients with physicians and behavioral health professionals or its providers, who treat various conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.
Teladoc Inc - Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with MarketBeat.com’s FREE daily email newsletter.
